Washington Trust Bank’s Novartis NVS Stock Holding History

Washington Trust Bank’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,285	Closed	-$216K	–	206
2019 Q4	$216K	Buy	+2,285	New	+$205K	0.03%	195
2019 Q3	–	Sell	-3,078	Closed	-$281K	–	193
2019 Q2	$281K	Sell	3,078 -357	-10%	-$30.2K	0.05%	159
2019 Q1	$296K	Sell	3,435 -884	-20%	-$71K	0.05%	156
2018 Q4	$332K	Hold	4,319	–	–	0.04%	171
2018 Q3	$333K	Sell	4,319 -1,339	-24%	-$99K	0.05%	169
2018 Q2	$383K	Sell	5,658 -105	-2%	-$7.25K	0.05%	157
2018 Q1	$418K	Buy	5,763 +105	+2%	+$7.99K	0.06%	146
2017 Q4	$426K	Hold	5,658	–	–	0.06%	158
2017 Q3	$435K	Buy	5,658 +765	+16%	+$57.8K	0.07%	140
2017 Q2	$366K	Buy	4,893 +16	+0.3%	+$1.13K	0.08%	140
2017 Q1	$325K	Hold	4,877	–	–	0.07%	160
2016 Q4	$318K	Hold	4,877	–	–	0.07%	152
2016 Q3	$345K	Buy	4,877 +391	+9%	+$28.5K	0.08%	137
2016 Q2	$332K	Buy	4,486 +89	+2%	+$6.15K	0.09%	128
2016 Q1	$285K	Sell	4,397 -162	-4%	-$11K	0.07%	143
2015 Q4	$351K	Buy	4,559 +1,769	+63%	+$141K	0.08%	141
2015 Q3	$230K	Sell	2,790 -1,829	-40%	-$163K	0.06%	171
2015 Q2	$407K	Buy	4,619 +22	+0.5%	+$2.02K	0.1%	122
2015 Q1	$406K	Sell	4,597 -317	-6%	-$28.1K	0.1%	129
2014 Q4	$408K	Buy	4,914 +385	+9%	+$31.9K	0.11%	144
2014 Q3	$382K	Sell	4,529 -1,917	-30%	-$155K	0.12%	145
2014 Q2	$523K	Buy	6,446 +243	+4%	+$19.1K	0.11%	131
2014 Q1	$473K	Buy	+6,203	New	+$452K	0.1%	136
2013 Q4	–	Sell	-4,530	Closed	-$315K	–	78
2013 Q3	$311K	Buy	4,530 +104	+2%	+$6.88K	0.08%	133
2013 Q2	$281K	Buy	+4,426	New	+$288K	0.08%	131

Other funds holding NVS

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Washington Trust Bank's NVS Position: Q1 2020 in Review

Washington Trust Bank sold out of Novartis (NVS) in Q1 2020, closing a stake of 2,285 shares — an estimated $216K sold.

Washington Trust Bank first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $523K in Q2 2014. 1,132 funds tracked by Wall St. Rank hold NVS as of Q1 2020.

Washington Trust Bank reported no remaining Novartis position as of Q1 2020 after selling out during the quarter.
Washington Trust Bank sold 2,285 Novartis shares in Q1 2020, an estimated $216K.
Washington Trust Bank first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
Washington Trust Bank's Novartis position peaked at $523K in Q2 2014.
1,132 funds tracked by Wall St. Rank held Novartis as of Q1 2020.

Based on Washington Trust Bank's 13F filing for Q1 2020, filed 1 May 2020.